Nationwide Fund Advisors’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-1,553
| Closed | -$179K | – | 2376 |
|
2017
Q3 | $179K | Hold |
1,553
| – | – | ﹤0.01% | 2686 |
|
2017
Q2 | $181K | Buy |
1,553
+362
| +30% | +$42.2K | ﹤0.01% | 2666 |
|
2017
Q1 | $147K | Sell |
1,191
-156
| -12% | -$19.3K | ﹤0.01% | 2713 |
|
2016
Q4 | $183K | Hold |
1,347
| – | – | ﹤0.01% | 2643 |
|
2016
Q3 | $268K | Hold |
1,347
| – | – | ﹤0.01% | 2488 |
|
2016
Q2 | $175K | Buy |
1,347
+789
| +141% | +$103K | ﹤0.01% | 2674 |
|
2016
Q1 | $52K | Sell |
558
-500
| -47% | -$46.6K | ﹤0.01% | 2979 |
|
2015
Q4 | $214K | Buy |
1,058
+537
| +103% | +$109K | ﹤0.01% | 2514 |
|
2015
Q3 | $76K | Sell |
521
-35
| -6% | -$5.11K | ﹤0.01% | 2964 |
|
2015
Q2 | $118K | Buy |
556
+316
| +132% | +$67.1K | ﹤0.01% | 2971 |
|
2015
Q1 | $55K | Buy |
+240
| New | +$55K | ﹤0.01% | 3085 |
|